Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 1, 2016
Event: Completion of an international acquisition and execution of a related credit facility.
Key Financial Metrics and Transaction Details
- Acquisition Consideration: Approximately $80 million in cash (subject to working capital adjustments).
- Assets Acquired: Substantially all assets and certain liabilities of Alphatec Holdings, Inc. subsidiaries in the UK, Italy, Netherlands, Germany, and Hong Kong; plus all equity interests in subsidiaries in Japan, Brazil, China, Singapore, and Australia.
- Debt Issued: Globus Medical provided a senior secured term loan facility to Alphatec Borrowers not to exceed $30 million.
- Initial Loan Disbursement: $25 million funded on the closing date.
- Loan Terms:
- Maturity: 5 years from closing.
- Interest Rate (Years 1-2): LIBOR + 8.0% (with a 9.5% floor).
- Interest Rate (Years 3-5): LIBOR + 13%.
- Supply Agreement: Alphatec to supply products to Globus Ireland and acquired subsidiaries for up to five years.
Material Changes
This filing reports a material change in the Company's operations and capital structure due to the expansion into new international markets via the acquisition of Alphatec's global subsidiaries. Additionally, the Company has assumed a new role as a lender, extending $25 million in debt to the seller (Alphatec) secured by the seller's assets.
Outlook, Risks, and Contingencies
- Financial Covenants: The Credit Agreement requires Alphatec Borrowers to maintain a fixed charge coverage ratio.
- Security Interest: Globus Medical holds a security interest in all assets of the Alphatec Borrowers.
- Integration: The transaction involves integrating operations across multiple jurisdictions (Europe, Asia, Australia, South America).
- Working Capital: The final purchase price is subject to customary post-closing adjustments based on working capital items.
Investor Verification Checklist
- Verify the final purchase price after working capital adjustments are calculated.
- Review the impact of the $25 million loan on Globus Medical's liquidity and balance sheet leverage.
- Assess the credit risk associated with the Alphatec Borrowers' ability to meet the fixed charge coverage ratio covenant.
- Confirm the terms and duration of the supply agreement with Alphatec to ensure continued product availability.
- Examine the press release (Exhibit 99.1) for management's strategic rationale and expected synergies.